Skip to main content
. 2023 Jan 23;12(2):254. doi: 10.3390/antiox12020254

Figure 4.

Figure 4

Figure 4

(a) The estimated binding geometry (2D (left) and 3D (right)) of myricitrin in 5NN8. The active side residues are named with three letters. (b) The estimated binding geometry (2D (left) and 3D (right)) of chlorogenic acid in 5NN8. The active side residues are named with three letters.